Non-invasive Brain Stimulation in Pediatric Migraine: A Perspective From Evidence in Adult Migraine.
non-invasive brain stimulation
pediatric migraine
therapeutics
transcranial direct current stimulation
transcranial magnetic stimulation
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2019
2019
Historique:
received:
31
12
2018
accepted:
25
03
2019
entrez:
30
4
2019
pubmed:
30
4
2019
medline:
30
4
2019
Statut:
epublish
Résumé
Pediatric migraine remains still a challenge for the headache specialists as concerns both diagnostic and therapeutic aspects. The less ability of children to describe the exact features of their migraines and the lack of reliable biomarker for migraine contribute to complicate the diagnostic process. Therefore, there's need for new effective tools for supporting diagnostic and therapeutic approach in children with migraine. Recently, promising results have been obtained in adult headache by means of application of neurostimulation techniques both for investigating pathophysiological mechanisms and also for therapeutical applications. Non-invasive brain stimulation (NIBS) techniques like transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) indeed proved to be generally safe and showing also some evidence of efficacy particularly for the symptomatic treatment. On such basis, in the last years increasing interest is rising in scientific pediatric community to evaluate the potential of such approaches for treatment pediatric headaches, particularly in migraine, even if the evidence provided is still very poor. Here we present a perspective for application of TMS and tDCS technique in children migraine principally based on evidence coming by studies in adults.
Identifiants
pubmed: 31031695
doi: 10.3389/fneur.2019.00364
pmc: PMC6473052
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
364Références
Brain. 2004 Jan;127(Pt 1):220-30
pubmed: 14607792
Clin Neurophysiol. 2004 Aug;115(8):1730-9
pubmed: 15261851
J Neurol Sci. 2004 Dec 15;227(1):67-71
pubmed: 15546593
Headache. 2005 Nov-Dec;45(10):1394-9
pubmed: 16324172
Annu Rev Biomed Eng. 2007;9:527-65
pubmed: 17444810
Neuron. 2007 Jul 19;55(2):187-99
pubmed: 17640522
Pain. 2009 Dec 15;147(1-3):132-40
pubmed: 19796876
Headache. 2010 Feb;50(2):290-300
pubmed: 20039963
Lancet Neurol. 2010 Apr;9(4):373-80
pubmed: 20206581
J Vis Exp. 2010 Apr 01;(38):null
pubmed: 20360672
Cochrane Database Syst Rev. 2010 Sep 08;(9):CD008208
pubmed: 20824873
Dev Med Child Neurol. 2010 Dec;52(12):1088-97
pubmed: 20875042
Cephalalgia. 2011 May;31(7):820-8
pubmed: 21398419
Headache. 2011 May;51(5):693-706
pubmed: 21521206
Headache. 2011 Sep;51(8):1254-66
pubmed: 21815889
Nat Rev Neurosci. 2011 Sep 20;12(10):570-84
pubmed: 21931334
Dev Med Child Neurol. 2012 Jul;54(7):636-9
pubmed: 22515662
Clin J Pain. 2012 Jun;28(5):452-61
pubmed: 22569218
Neurol Sci. 2013 Jun;34(6):819-30
pubmed: 23263736
Neuropediatrics. 2013 Feb;44(1):3-19
pubmed: 23303551
Pain. 2013 Dec;154 Suppl 1:S44-53
pubmed: 23891892
Handb Clin Neurol. 2013;116:585-98
pubmed: 24112926
Transl Neurosci. 2013 Jun;4(2):null
pubmed: 24163755
BMJ. 2014 Apr 07;348:g2285
pubmed: 24711666
Brain Stimul. 2015 Jan-Feb;8(1):76-87
pubmed: 25499471
Clin Neurophysiol. 2015 Jun;126(6):1071-1107
pubmed: 25797650
J Neurol Sci. 2015 Jul 15;354(1-2):103-9
pubmed: 26003225
J Biol Regul Homeost Agents. 2016 Apr-Jun;30(2):333-8
pubmed: 27358118
Clin Neurophysiol. 2017 Jan;128(1):56-92
pubmed: 27866120
Headache. 2017 Apr;57(4):685-691
pubmed: 28295242
Brain Behav Immun. 2017 Aug;64:152-161
pubmed: 28427911
J Headache Pain. 2017 Dec;18(1):70
pubmed: 28726157
Brain Stimul. 2018 Mar - Apr;11(2):278-288
pubmed: 29169814
Cephalalgia. 2018 May;38(6):1038-1048
pubmed: 29504483
Headache. 2018 May;58(5):724-731
pubmed: 29528485
Front Neurosci. 2018 Nov 29;12:884
pubmed: 30555295